Loading...
Lawrence Walter — Saxagliptin Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #9 for Saxagliptin · $2.2K export value · DGFT Verified
Lawrence Walter is the #9 Indian exporter of Saxagliptin with $2.2K in export value and 48 verified shipments. Lawrence Walter holds a 0.1% market share in Saxagliptin exports across 2 countries. The company exports 8 pharmaceutical products worth $2.0M across 4 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $2.1M | 42 | 85.6% |
| IRAQ | $288.3K | 12 | 11.7% |
| SINGAPORE | $33.1K | 20 | 1.3% |
| MAURITIUS | $24.5K | 102 | 1.0% |
| KENYA | $2.1K | 4 | 0.1% |
| SOMALIA | $1.6K | 14 | 0.1% |
| BELGIUM | $1.5K | 29 | 0.1% |
| SWITZERLAND | $728 | 19 | 0.0% |
| YEMEN | $340 | 2 | 0.0% |
| EGYPT | $331 | 1 | 0.0% |
India exports Saxagliptin to 16 countries. The top destination is UNITED STATES (85.6%), followed by IRAQ and SINGAPORE.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MYLAN PHARMACEUTICALS INC, | UNITED STATES | $850.0K | 17 |
| MYLAN PHARMACEUTICALS INC | UNITED STATES | $850.0K | 17 |
| ALSHIFA PHARMA SCIENTIFIC DRUG | IRAQ | $259.3K | 10 |
| GLENMARK PHARMACEUTICALS INC | UNITED STATES | $45.2K | 2 |
| MYLAN PHARMACEUTICALS INC,. | UNITED STATES | $25.7K |
India exported $2.3M worth of Saxagliptin through 258 shipments from 30 suppliers to 16 countries, serving 41 buyers globally. Lawrence Walter contributes $2.2K to this total, accounting for 0.1% of India's Saxagliptin exports.
Lawrence Walter's average Saxagliptin shipment value is $46 per consignment, based on 48 shipments totaling $2.2K.
Lawrence Walter ranks #9 among 30 Indian Saxagliptin exporters with a 0.1% market share. The top 3 exporters are MYLAN LABORATORIES LIMITED ($2.0M), SAM LIFESTYLE ($259.3K), LOTUS INTERNATIONAL ($18.9K). Lawrence Walter processed 48 shipments to 2 destination countries.
What Lawrence Walter must comply with to export Saxagliptin to its top destination countries
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
Exporters ranked immediately above and below #9 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | HEXA HEALTH CARE PRIVATE LIMITED | $4.0K | 9 | 1 | $447 |
| 8 | SAVA HEALTHCARE LIMITED | $3.4K | 54 | 1 | $62 |
| 9 | LAWRENCE WALTER ★ | $2.2K | 48 | 2 | $46 |
| 10 | RMPL PHARMA LLP | $1.6K | 14 | 1 | $112 |
| 11 | HEXA HEALTHCARE PVT.LTD., |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 102 | 39.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 26 | 10.1% |
| Bombay Air | 26 | 10.1% |
| DELHI AIR CARGO ACC (INDEL4) | 23 | 8.9% |
| DELHI AIR | 20 | 7.8% |
| MUNDRA SEA | 12 | 4.7% |
| CHENNAI AIR | 6 | 2.3% |
| JNPT | 6 | 2.3% |
Lawrence Walter also exports these advanced diabetes medications products. Each links to the detailed product page.
Lawrence Walter exports 8 products worth $2.0M. Beyond Saxagliptin, top products include Empagliflozin, Fluticasone, Mesalamine, Canagliflozin, Linagliptin. View the complete Lawrence Walter profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Saxagliptin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Lawrence Walter's Saxagliptin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Lawrence Walter
Full Company Profile →
8 products · $2.0M total trade · 4 categories
| 3 |
| REGENCY PHARMA LIMITED | MAURITIUS | $17.0K | 77 |
| SUCCESS INTER LINK PTE LTD | SINGAPORE | $12.3K | 4 |
| VERONA PHARMACY PTE LTD.- | SINGAPORE | $6.2K | 7 |
| VERONA PHARMACY PTE LTD. | SINGAPORE | $3.7K | 2 |
| REGENCY PHARMA LTD | MAURITIUS | $3.4K | 16 |
India's Saxagliptin is purchased by 41 buyers worldwide. The top buyer is MYLAN PHARMACEUTICALS INC, (UNITED STATES), followed by MYLAN PHARMACEUTICALS INC and ALSHIFA PHARMA SCIENTIFIC DRUG.
| $1.1K |
| 8 |
| 1 |
| $137 |
Lawrence Walter ranks #9 among 30 Indian Saxagliptin exporters. Average shipment value of $46 compared to the market average of $77.3K. The closest competitors by value are HEXA HEALTH CARE PRIVATE LIMITED and SAVA HEALTHCARE LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 16+ countries, 41+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Lawrence Walter.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Saxagliptin. For current shipment-level data, contact TransData Nexus.